Skip to main content
. 2022 Jul 26;164(9):2453–2464. doi: 10.1007/s00701-022-05301-y

Table 6.

Update on nomenclature of adult gliomas

WHO 2016 Classification of CNS Tumours
Diffuse astrocytic and oligodendroglial tumours
WHO 2021 Classification of CNS Tumours
Gliomas, glioneuronal tumours and neuronal tumours
Adult-type diffuse gliomas
Diffuse astrocytoma, IDH-mutant, WHO grade II Astrocytoma, IDH-mutant, CNS WHO grade 2
Anaplastic astrocytoma, IDH-mutant, WHO grade III Astrocytoma, IDH-mutant, CNS WHO grade 3
Glioblastoma, IDH-mutant WHO grade IV (secondary glioblastoma) Astrocytoma, IDH-mutant, CNS WHO grade 4
Diffuse astrocytoma, IDH-wildtype, WHO grade II* Glioblastoma, IDH-wildtype, CNS WHO grade 4
Anaplastic astrocytoma, IDH-wildtype, WHO grade III*
Glioblastoma, IDH-wildtype, WHO grade IV (primary glioblastoma)
Oligodendroglioma, IDH-mutant and 1p/19q codeleted, WHO grade II Oligodendroglioma, IDH-mutant and 1p/19q codeleted, CNS WHO grade 2
Anaplastic oligodendroglioma, IDH-mutant and 1p/19q codeleted WHO grade III Oligodendroglioma, IDH-mutant and 1p/19q codeleted, CNS WHO grade 3

*Detection of TERTp mutation, EGFR amplification, and/or +7/−10 (Table inspired by [42])